Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NHE1 inhibitors(Sodium/hydrogen exchanger 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationRare Pediatric Disease (US), Orphan Drug (EU) |
Molecular FormulaC11H15N3O5S2 |
InChIKeyGROMEQPXDKRRIE-UHFFFAOYSA-N |
CAS Registry187870-78-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Rimeporide | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Failure | Phase 2 | DE | - | |
Muscular Dystrophy, Duchenne | Phase 1 | - | - | |
Myotonic Dystrophy | Preclinical | CH | - |
Phase 1 | 20 | (Cohort 1) | hlnkfpfiym(whhudypive) = bwhkbangfy xncfsthbuv (kpldbbwsra, qxnftuqqdb - kzifsztcld) View more | - | 18 Jul 2019 | ||
(Cohort 2) | hlnkfpfiym(whhudypive) = yhfwfcgxfb xncfsthbuv (kpldbbwsra, buexugrwiv - omajgdszsk) View more |